Адипонектин у мужчин с абдоминальным ожирением

Полный текст:

Список литературы

1. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ. 2001;2(9):56-60.

2. Abbasi F, Chu J, Lamendola C. et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes. 2004;53:585-590.

3. Baratta R, Amato S, Degano C. et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. Journal of Internal Medicine. 2005;257 (2):167-175.

4. Chandran M, Phillips S, Сiaraldi T. et al. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26:2442-2450.

5. Fruhbeck G, Gomez-Ambrosi J. et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. AJP Endocrinology and Metabolism. 2001;280:Е827-Е847.

6. Matsubara M, Maruoka S, Katayose S. Clinical study: inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology. 2002;147:173-180.

7. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin сoncentrations in women with dyslipidemia. J Clin Endocrinol & Metab. 2002;87:2764-2769.

8. Matsuzawa Y, Funahashi T, Kihara S. Adiponectin and metabolic syndrome. Arteriosclerosis, thrombosis and vascular biology. 2004;24:29.

9. Pischon T, Girman C, Hotamisligil G. et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730-1737.

10. Ryan A, Berman D, Nicklas B et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003;26(8): 2383-2388.

11. Saltiel A. You are what you secrete. Nat Med. 2001;7(8):887-8.

12. Saltiel A, Kahn C. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799-806.

13. Shand B, Scott R, Elder P. et al. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes, Obesity and Metabolism. 2003;5:349-53.

14. Shapiro L, Scherer P. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology. 1998;8(6):335-8.

15. Stefan N, Vozarova B, Funahashi T. et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884-8.

16. Tschritter O, Fritsche A, Thamer C. et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239-243.

17. Vasseur F, Lepretre F, Lacquemant C. et al. The genetics of adiponectin. Curr Diab Rep. 2003;3:151-8.

18. Vendrell J, Broch M, Vilarrasa N. et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationship in obesity. Obes Res. 2004;12:962-971.

19. Weyer C, Funahashi T, Tanaka S. et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol & Metab. 2001;85(5):1930-1935.

20. Yang W-S, Lee W-J, Funahashi T. et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res. 2002;10:1104-1110.

Для цитирования:

Butrova S.A., Ershova E.V., Il'in A.V., Mel'nichenko G.A. Адипонектин у мужчин с абдоминальным ожирением. Ожирение и метаболизм. 2006;3(2):32-36.

For citation:

., ., ., . Adiponektin u muzhchin s abdominal'nym ozhireniem. Obesity and metabolism. 2006;3(2):32-36. (In Russ.)

Просмотров: 19

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)